A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

Clinical trial NCT04583995 · COMPLETED

Trial details

NCT number: NCT04583995
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection COVID-19

Start date: 2020-09-28
Primary completion: 2022-03-29
Enrollment: 15185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.